Novavax Inc (NAS:NVAX)
$ 17.47 2.44 (16.23%) Market Cap: 2.57 Bil Enterprise Value: 1.99 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Novavax Inc at Bank of America Biotech SMID Cap Conference Transcript

Dec 07, 2022 / 02:10PM GMT
Release Date Price: $17.22 (+2.62%)
Operator

Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Alec Stranahan. You may begin.

Alec Warren Stranahan
BofA Securities, Research Division - Associate

Okay. Hello, everyone. Welcome to day 1 of the 2022 Bank of America Biotech Conference. Thank you for joining this session with Novavax. My name is Alec Stranahan. I'm Vice President and Senior Biotech analyst here at BofA. And I'm pleased to be joined by John Trizzino, Chief Commercial Officer and Chief Business Officer; as well as Filip Dubovsky Executive Vice President and Chief Medical Officer. Thanks for joining guys.

John Joseph Trizzino
Novavax, Inc. - Executive VP and Chief Business & Commercial Officer

Thank you, Alec. Good to be here.

Questions & Answers

Alec Warren Stranahan
BofA Securities, Research Division - Associate

Perfect

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot